Discontinuation report STEGLUJAN

Last updated on 2021-02-04 History
Report ID 133310
Drug Identification Number 02475901
Brand name STEGLUJAN
Common or Proper name Ertugliflozin Sitagliptin tablets
Company Name MERCK CANADA INC
Market Status DORMANT
Active Ingredient(s) ERTUGLIFLOZIN SITAGLIPTIN
Strength(s) 5MG 100MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 30
ATC code A10BD
ATC description
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2021-02-03
Remaining supply date 2021-02-03
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2021-02-04 French Compare
v1 2021-02-04 English Compare